1
|
Petreanu CA, Vlăsceanu S, Zaharia D, Jipa D, Moldovan H, Gheorghiță D, Iliuță L, Rădulescu B, Bădărău IA, Savu CF. Spontaneous Pulmonary Hematoma: Case Report of a Giant Post-COVID-19 Hematoma and Literature Review. Healthcare (Basel) 2023; 11:527. [PMID: 36833061 PMCID: PMC9957326 DOI: 10.3390/healthcare11040527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2022] [Revised: 01/04/2023] [Accepted: 01/06/2023] [Indexed: 02/12/2023] Open
Abstract
Pulmonary hematomas are a rare pathology. Although they are usually reported post-traumatically, there are also spontaneous forms in pulmonary pathologies or during drug therapy. In these spontaneous entities, primitive forms are rarely described, although the contributory local pulmonary pathological terrain or a specific associated medication has not yet been identified. We present the case of a patient who developed a giant pulmonary hematoma that appeared spontaneously during recovery from COVID-19 infection. It appeared in one of the two bullae-like cystic lung lesions developed during secondary COVID-19 infection. The clinical impact was major, with hypotension and anemia being observed, requiring hemodynamic support and the adjustment of drug therapy. The clinical course was favorable, with a quasi-complete resolution of both the hematoma and a second cystic lesion being observable at 8 months by pulmonary remodeling. Spontaneous pulmonary hematomas may constitute a pathological entity associated with a post-COVID-19 remodeling process of the lung and the related anticoagulant treatment, which should be recognized, especially in the actual COVID-19 pandemic or in the widespread use of anticoagulant treatment. Conservative treatment is the method of choice, even in giant lung forms.
Collapse
Affiliation(s)
- Cornel Adrian Petreanu
- Department of Thoracic Surgery, “Marius Nasta” National Institute of Pneumology, 050152 Bucharest, Romania
- Thoracic Surgery Clinic I, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| | - Silviu Vlăsceanu
- Department of Thoracic Surgery, “Marius Nasta” National Institute of Pneumology, 050152 Bucharest, Romania
- Department of Physiology, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| | - Dragoș Zaharia
- Department of Pneumology, “Marius Nasta” National Institute of Pneumology, 050152 Bucharest, Romania
- Pneumology Clinic, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| | - Daniela Jipa
- Department of Pneumology, “Marius Nasta” National Institute of Pneumology, 050152 Bucharest, Romania
- Pneumology Clinic, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| | - Horațiu Moldovan
- Department of Cardiovascular Surgery, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Cardiovascular Surgery, Clinical Emergency Hospital Bucharest, 014461 Bucharest, Romania
- Academy of Romanian Scientists, 050045 Bucharest, Romania
| | - Daniela Gheorghiță
- Faculty of Materials Science and Engineering, Politehnica University of Bucharest, 060042 Bucharest, Romania
| | - Luminița Iliuță
- Department of Medical Informatics and Biostatistics, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
| | - Bogdan Rădulescu
- Department of Cardiovascular Surgery, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
- Department of Cardiovascular Surgery, Prof. Dr. C.C. Iliescu Emergency Institute for Cardiovascular Diseases, 022322 Bucharest, Romania
| | - Ioana Anca Bădărău
- Department of Physiology, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| | - Cornel Florentin Savu
- Department of Thoracic Surgery, “Marius Nasta” National Institute of Pneumology, 050152 Bucharest, Romania
- Thoracic Surgery Clinic I, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania
| |
Collapse
|
2
|
van Roozendaal LM, van Gool MH, Sprooten RTM, Maesen BAE, Poeze M, Hulsewé KWE, Vissers YLJ, de Loos ER. Surgical treatment of bronchial rupture in blunt chest trauma: a review of literature. J Thorac Dis 2018; 10:5576-5583. [PMID: 30416808 DOI: 10.21037/jtd.2018.08.22] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
Bronchial rupture by blunt chest trauma is rare. We present a case of bronchial injury after blunt chest trauma that was repaired surgically by primary reconstruction. We performed a review of literature to verify if primary reconstruction is suitable for the treatment of adult patients with blunt bronchial injury. A systematic search was conducted to identify cohort studies of bronchial rupture after blunt chest trauma in adult patients between 1985 and 2016 (n=215 articles). Studies were included concerning four or more patients and in case patient data could be extracted. This resulted in 19 articles for final review, consisting of 155 patients. Mean age of 155 patients was 28 (range, 18-60) years. The main bronchus was mostly injured (81%), in 5% including an injury of the trachea and in 14% lobar bronchi injury. Surgical repair was performed in 95% of patients: primary anastomosis in 72%, pneumonectomy in 15%, lobectomy or sleeve resection in 12% and other in 1%. Perioperative mortality rate was 10%. Other complications occurred in 17% (empyema, rebleeding, stenosis and fistula, among others). Data concerning the occurrence of long-term complications or long-term follow-up was not found. Statistical evaluation could not be performed due to lack of consistent patient data. No strong recommendations regarding type and timing of surgery can be made based on the available literature. Based on our multidisciplinary opinion we would advocate primary anastomosis in case of stable vital signs with the goal to preserve healthy lung parenchyma. Moreover, it may be considered transferring these rare cases to an experienced thoracic and trauma surgery center.
Collapse
Affiliation(s)
| | | | | | | | | | - Karel W E Hulsewé
- Department of Surgery, Zuyderland Medical Center, Heerlen, The Netherlands
| | - Yvonne L J Vissers
- Department of Surgery, Zuyderland Medical Center, Heerlen, The Netherlands
| | - Erik R de Loos
- Department of Surgery, Zuyderland Medical Center, Heerlen, The Netherlands
| |
Collapse
|
3
|
Danielyan SN, Abakumov MM, Tarabrin EA, Kokov LS, Gasanov AM, Wilk AP, Saprin AA. [The features of diagnosis and treatment of traumatic and non-traumatic pulmonary bleeding]. Khirurgiia (Mosk) 2017:24-32. [PMID: 28805775 DOI: 10.17116/hirurgia2017824-32] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
AIM To analyze an efficacy of differentiated approach for pulmonary bleeding of different etiology and severity. MATERIAL AND METHODS The study included 134 cases of pulmonary bleeding for the period 2006-2015 including 53 patients with traumatic and 81 with non-traumatic etiology. Men/women ratio was 2.7:1, mean age was 43 years. Comparative retrospective analysis of X-ray and CT data in diagnosis of bleeding source was performed. Bronchoscopy was used to confirm these data. There were 43 endovascular examinations including 40 cases of bronchial arteriography (BAG). RESULTS AND DISCUSSION X-ray and CT-signs of bleeding source were detected more often in case of traumatic pulmonary bleeding (62.3% and 93%) compared with non-traumatic (27.2 and 54%; p<0.05). Bronchoscopy revealed ongoing pulmonary bleeding in 40 (30%) patients, completed - in 94 (70%) patients. Indirect angiographic signs were the most frequent for pulmonary bleeding origin: hypervascularization (32.6%), bronchial-pulmonary shunts (23.2%) and bronchial artery dilatation (20.9%). 17 patients with ongoing bleeding underwent bronchial obstruction with adequate hemostasis in all cases. Endovascular interventions included bronchial arteries embolization (EBA) (33), occlusion of intercostal arteries (3) and segmental branches of low-lobar pulmonary artery (1), aortic stenting (1). Early efficacy of EBA was 97% with 2 month recurrence of pulmonary bleeding near 12.5%. Ongoing traumatic pulmonary bleeding was an indication for emergency thoracotomy in 18.9% compared with 12.3% for non-traumatic bleeding when surgery was made after endoscopic and endovascular hemostasis. CONCLUSION Differentiated approach depending on etiology and severity of pulmonary bleeding improves outcomes and reduces the number of operations for ongoing severe bleeding.
Collapse
Affiliation(s)
- Sh N Danielyan
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - M M Abakumov
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - E A Tarabrin
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - L S Kokov
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - A M Gasanov
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - A P Wilk
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| | - A A Saprin
- Sklifosovsky Research Institute for Emergency Care, Health Care Department of Moscow, Moscow, Russia
| |
Collapse
|